Akademik Veri Yönetim Sistemi
ASTHMA ALLERGY IMMUNOLOGY, 2024 (ESCI)
Chronic spontaneous urticaria (CSU) is a heterogeneous disease that significantly affects patients' quality of life due to its unpredictable nature and discomforting symptoms. Due to the variable course of the disease, the current condition of the disease should be comprehensively evaluated at every visit by healthcare providers. However, objective and specific biomarkers are lacking. Information about disease activity, disease control and quality of life can only be obtained from patients' reports regarding their health status, symptoms, life quality, or improvements during treatment. To do that, using patient-reported outcomes (PROs) is crucial in assessing the effectiveness of treatments, making decisions about treatment changes, and evaluating the patient's general well-being. This article will provide information about current validated PROs recommended by guidelines for evaluating CSU.